Defensin-Mediated Oral Immunity: A Systematic Review and Meta-Analysis of DEFB1 Expression in Preventive Dentistry Strategies
DOI:
https://doi.org/10.36283/ziun-pjmd14-3/059Keywords:
β‑Defensins, Oral Mucosal Immunity, Dental Caries, Periodontitis, Preventive Dentistry, Gene PolymorphismAbstract
Background: Human beta-defensin 1 (DEFB1), together with other defensins, serves as a fundamental immune protector for oral tissues since it suppresses harmful microbial growth and fosters healthy oral conditions. The research included two main purposes assessing the relationship between DEFB1 expression levels and genetic polymorphism with oral disease risks, and evaluating DEFB1's potential for oral disease prevention biomarker use.
Methods: This research performed a systematic review and meta-analysis on 11 observational studies using PubMed, Google Scholar, and Web of Science databases. The data extraction process concentrated on recording DEFB1 expression data together with clinical results and population characteristics. The risk-of-bias tools were done using the Newcastle Ottawa tool, while a random-effects model was applied for meta-analysis due to heterogeneity in the studies.
Results: Eleven studies that contained DEFB1 gene polymorphisms and expression were considered. Rs11362 and rs1799946 polymorphisms and low levels of DEFB1 gene/protein were linked to increased risks of oral diseases, such as caries and periodontitis. The effect sizes were noted as 2.26 (95% CI: 0.90 -5.67) and -0.59 (95% CI: -1.28 to 0.09). Subgroup and sensitivity analyses showed the same direction of effect. Nonetheless, the significant heterogeneity was recorded (I2 > 90 percent), and the overall certainty of evidence was low because of the study design, inconsistency, and imprecision.
Discussion: Research findings show that DEFB1 demonstrates potential as an indicator of susceptibility to diseases, although specific studies exhibit some variation in their results. Additional research needs standardized approaches to advance knowledge.
References
1. Ansari Moghadam S, Pishadast S, Gholami L, Alijani E, Ansari Moghadam A, Hadilou M. Comparison of salivary beta-defensin-1 levels in patients with periodontitis before and after phase I periodontal therapy. J Adv Periodontol Implant Dent. 2024 Jan; 16(1):30-35. doi:10.34172/japid.2024.002
2. Sulijaya B, Masulili SLC, Auerkari EI. Human Beta-defensin-1 and Periodontal Disease: The Past, Present, and Future. Journal of Indonesian Dental Association. 2021 Apr; 4(1):61-68. doi:10.32793/jida.v4i1.624
3. Chen M, Hu Z, Shi J, Xie Z. Human β-defensins and their synthetic analogs: Natural defenders and prospective new drugs of oral health. Life Sci. 2024 Jun 1;346:122591. doi: 10.1016/j.lfs.2024.122591.
4. Atalay N, Balci N, Gürsoy M, Gürsoy UK. Systemic Factors Affecting Human Beta-Defensins in Oral Cavity. Pathogens. 2024 Aug 2;13(8):654. doi: 10.3390/pathogens13080654.
5. Farag AGA, Shoeib MAA, Labeeb AZ, Sleem AS, Khallaf HMA, Khalifa AS, et al. Human beta-defensin 1 circulating level and gene polymorphism in non-segmental vitiligo Egyptian patients. An Bras Dermatol. 2023 Dec; 98:181-188. doi:https://doi.org/10.1016/j.abd.2022.04.002
6. Emulina DE, Abola I, Brinkmane A, Isakovs A, Skadins I, Moisejevs G, et al. The Impact of IL1B rs1143634 and DEFB1 rs11362 Variants on Periodontitis Risk in Phenylketonuria and Type 1 Diabetes Mellitus Patients in a Latvian Population. Diagnostics (Basel). 2024 Jan 16;14(2):192. doi: 10.3390/diagnostics14020192.
7. Wang L, Yang H, Cao L, Yang Y, Ding R. Integrative genomic pan-cancer analysis reveals the prognostic significance of DEFB1 in tumors. Discov Onc. 2025 Apr; 16(1):552. doi:10.1007/s12672-025-02340-6
8. Adyns L, Proost P, Struyf S. Role of Defensins in Tumor Biology. Int J Mol Sci. 2023 Mar 9;24(6):5268. doi: 10.3390/ijms24065268.
9. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021 March 29;372:n71. 10.1136/bmj.n71.
10. Antunes LS, Carvalho L, Petean IBF, Antunes LA, Freitas JV, Salles AG, et al. Association between genetic polymorphisms in the promoter region of the defensin beta 1 gene and persistent apical periodontitis. Int Endod J. 2021 Jan;54(1):38-45. doi: 10.1111/iej.13401.
11. Ikuta T, Inagaki Y, Tanaka K, Saito T, Nakajima Y, Bando M, et al. Gene polymorphism of β-defensin-1 is associated with susceptibility to periodontitis in Japanese. Odontology. 2015 July; 103(1):66-74. doi:10.1007/s10266-013-0139-9
12. Loo WT, Bai LJ, Fan CB, Yue Y, Dou YD, Wang M, et al. Clinical application of human β-defensin and CD14 gene polymorphism in evaluating the status of chronic inflammation. J Transl Med. 2012 Sep 19;10 Suppl 1(Suppl 1):S9. doi: 10.1186/1479-5876-10-S1-S9.
13. Nelson-Filho P, Azulay M, Küchler EC, da Silva LA, da Silva RA, Vasconcelos KR, et al. Association between polymorphisms in the gene encoding beta-defensin 1 and gingivitis, in children. Rev Sul-Bras Odontol. 2022 Nov 7;19(2):322‑0. doi:10.21726/rsbo.v19i2.1873
14. Li X, Duan D, Yang J, Wang P, Han B, Zhao L, et al. The expression of human β-defensins (hBD-1, hBD-2, hBD-3, hBD-4) in gingival epithelia. Arch Oral Biol. 2016 Jan; 66:15-21. doi:10.1016/j.archoralbio.2016.01.012
15. Wu L, Li Z, Zhou J, Ma B, Yu F, Zheng X, et al. An association analysis for genetic factors for dental caries susceptibility in a cohort of Chinese children. Oral Diseases. 2022 Oct; 28(2):480-494. doi:10.1111/odi.13758
16. Han Q, Wang R, Sun C, Jin X, Liu D, Zhao X, et al. Human Beta-Defensin-1 Suppresses Tumor Migration and Invasion and Is an Independent Predictor for Survival of Oral Squamous Cell Carcinoma Patients. PLOS ONE. 2014 Mar; 9(3):e91867. doi:10.1371/journal.pone.0091867
17. Nazemisalman B, Baheran V, Shokrani MR, Taheri SS. Comparing salivary antibacterial peptides in children with and without Caries. Journal of Pediatric Perspectives. 2023 Sep; 11(9):18212-18219. doi:10.22038/ijp.2023.74229.5349
18. Gürsoy UK, Gürsoy M, Liukkonen A, Suominen AL, Könönen E. Salivary Human β-Defensin 1-3 and Human α-Defensin-1 Levels in Relation to the Extent of Periodontal Disease and Tooth Loss in the Elderly. J Clin Med. 2023 Jan; 12(3):976. doi:10.3390/jcm12030976
19. Zupin L, Celsi F, Bresciani M, Orzan E, Grasso DL, Crovella S. Human beta defensin-1 is involved in the susceptibility to adeno-tonsillar hypertrophy. International Journal of Pediatric Otorhinolaryngology. 2018 Jan; 107:135-139. doi:10.1016/j.ijporl.2018.01.041
20. M W, S L, I U, A Z, Am K, Ar P. Gene expression of human beta defensins-1 and -2 is significantly reduced in non-inflamed keratinized oral tissue of smokers. Journal of dentistry. 2012 Jul; 40(11). doi:10.1016/j.jdent.2012.07.017
21. Rahmayanti F, Wimardhani YS, Irfani R. Salivary human beta defensin-1 level and oral health status of Tobacco smokers. Journal of International Dental and Medical Research. 2019 Nov; (4):1573-1576.
22. Ghosh SK, Man Y, Fraiwan A, Waters C, McKenzie C, Lu C, et al. Beta-defensin index: A functional biomarker for oral cancer detection. Cell Rep Med. 2024 Mar 19;5(3):101447. doi: 10.1016/j.xcrm.2024.101447.
23. Hemati G, Imani MM, Choubsaz P, Inchingolo F, Sharifi R, Sadeghi M, et al. Evaluation of Beta-Defensin 1 and Mannose-Binding Lectin 2 Polymorphisms in Children with Dental Caries Compared to Caries-Free Controls: A Systematic Review and Meta-Analysis. Children (Basel). 2023 Jan 28;10(2):232. doi: 10.3390/children10020232.
24. Kompuinen J, Keskin M, Yilmaz D, Gürsoy M, Gürsoy UK. Human β-Defensins in Diagnosis of Head and Neck Cancers. Cells. 2023 Mar 7;12(6):830. doi: 10.3390/cells12060830.
25. Negm HMH, Farag AF, Taha RROO. Polymorphisms in ENAM, AMBN, and KLK4 predispose Egyptian adults to dental caries: A cross-sectional study. Saudi Dent J. 2024 Jun;36(6):915-919. doi: 10.1016/j.sdentj.2024.03.014.
26. Zou T, Foxman B, McNeil DW, Weinberg SM, Marazita ML, Shaffer JR. Genome-Wide Analysis of Dental Caries Variability Reveals Genotype-by-Environment Interactions. Genes (Basel). 2023 Mar 17;14(3):736. doi: 10.3390/genes14030736.
27. González‑Casamada C, Molina‑Frechero N, Espinosa‑Cristóbal LF, García‑López S, Castañeda‑Castaneira E. Polymorphisms associated with dental caries in pediatric populations: a systematic review. Rev Med Inst Mex Seguro Soc. 2023 Jul 31;61(4):502–508. doi:10.5281/zenodo.8200501.
28. Koopaie M, Shahri FK, Montazeri R, Kolahdooz S, Shahri MM, Moshkbouy E. Comparison of salivary statherin and beta-defensin-2 levels, oral health behaviors, and demographic factors in children with and without early childhood caries. BMC Oral Health. 2025 May 31;25(1):868. doi: 10.1186/s12903-025-06252-3.
29. Fareed MM, Ullah S, Aziz S, Johnsen TA, Shityakov S. In-silico analysis of non-synonymous single nucleotide polymorphisms in human β-defensin type 1 gene reveals their impact on protein-ligand binding sites. Comput Biol Chem. 2022 Jun;98:107669. doi: 10.1016/j.compbiolchem.2022.107669.
30. Ma F, He H, Chen S, Yu X, Liu Q, Zeng X. Associations of PART1 and DEFB1 polymorphisms with Dental Caries in twelve-year-old children in Southern China: a cross-sectional study. BMC Pediatr. 2023 Jan 4;23(1):6. doi: 10.1186/s12887-022-03678-4.
31. Uemura I, Takahashi-Suzuki N, Sano A, Yamada S, Nakata A, Satoh T. Curcumin effects on age-related changes in oral immunity: an in vivo study. Br J Nutr. 2024 Jul 14;132(1):31-39. doi: 10.1017/S0007114524000801.
32. Duan J, Wang H, Liu M, Chen Y, Li N, Liu J, et al. Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma. Chin J Cancer Res. 2024 Aug 30;36(4):351-367. doi: 10.21147/j.issn.1000-9604.2024.04.01.
33. Liu J, Ye SY, Xu XD, Liu Q, Ma F, Yu X, et al. Multiomics analysis reveals the genetic and metabolic characteristics associated with the low prevalence of dental caries. J Oral Microbiol. 2023 Nov 2;15(1):2277271. doi: 10.1080/20002297.2023.2277271.
34. Winter J, Jepsen S. Role of innate host defense proteins in oral cancerogenesis. Periodontol 2000. 2024 Oct;96(1):203-220. doi: 10.1111/prd.12552.
35. Shi J, Hu Z, Zhou Y, Zuo M, Wu H, Jin W, et al. Therapeutic Potential of Synthetic Human β-Defensin 1 Short Motif Pep-B on Lipopolysaccharide-Stimulated Human Dental Pulp Stem Cells. Mediators Inflamm. 2022 Jan 24;2022:6141967. doi: 10.1155/2022/6141967.
36. Aruna P, Patil SS, Muthu MS, Vettriselvi V, Arockiam S, Kirubakaran R, et al. Association between polymorphisms of immune response genes and early childhood caries - systematic review, gene-based, gene cluster, and meta-analysis. J Genet Eng Biotechnol. 2023 Nov 16;21(1):124. doi: 10.1186/s43141-023-00566-x.
37. Inomata M, Abe M, Kawase Y, Hayashi T, Amano S, Sakagami H. Dectin-1/SYK Activation Induces Antimicrobial Peptide and Negative Regulator of NF-κB Signaling in Human Oral Epithelial Cells. In Vivo. 2024 May-Jun;38(3):1042-1048. doi: 10.21873/invivo.13537.
38. Ślebioda Z, Woźniak T, Dorocka-Bobkowska B, Woźniewicz M, Kowalska A. Beta-defensin 1 gene polymorphisms in the pathologies of the oral cavity-Data from meta-analysis: Association only with rs1047031 not with rs1800972, rs1799946, and rs11362. J Oral Pathol Med. 2021 Jan;50(1):22-31. doi: 10.1111/jop.13136.
39. Laberge S, Akoum D, Wlodarczyk P, Massé JD, Fournier D, Semlali A. The Potential Role of Epigenetic Modifications on Different Facets in the Periodontal Pathogenesis. Genes (Basel). 2023 May 30;14(6):1202. doi: 10.3390/genes14061202.
40. Mohan V, Patro SK, Purohit P, Sharma V, Soni K, Choudhury B, et al. Pioneering Clinical Investigation: Beta Defensin Expression in Patients of Squamous Cell Carcinoma of Oral Cavity as a Forward-Looking Validation for Molecular Treatment. Indian J Otolaryngol Head Neck Surg. 2025 Jan;77(1):149-154. doi: 10.1007/s12070-024-05129-1.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
